Genomic epidemiology of SARS-CoV-2 in Senegal in 2020-2021
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.17796 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Adjiratou Aissatou Ba und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Bactériologie-Virologie CHNU Aristide le Dantec, Dakar, Sénégal. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Genome, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In Senegal, molecular diagnosis was widely used for the detection and management of COVID-19 patients. However, genomic surveillance was very limited in the public sector. This study aimed to share the experience of a Senegalese public sector laboratory in response to the COVID-19 pandemic, and to describe the distribution of variants circulating in 2020 and 2021. Methodology: From July 2020 to December 2021, SARS-CoV-2 qRT-PCR was performed on nasopharyngeal samples from travelers and symptomatic patients at the Bacteriology and Virology Laboratory (LBV) of the Aristide le Dantec University Teaching Hospital. Samples with a cycle threshold (Ct) ≤ 30 were selected for whole-genome sequencing (WGS) using the Nanopore technology. In-house scripts were developed to study the spatial and temporal distribution of SARS-CoV-2 variants in Senegal, using our sequences and those retrieved from the GISAID database.
Results
Of 8,207 patients or travelers screened for SARS-CoV-2, 970 (11.8%) were positive and 386 had a Ct ≤ 30. WGS was performed on 133 samples. Concomitantly with high-quality sequences deposited in the GISAID database covering nine cities in Senegal in 2020 and 2021 (n = 1,539), we observed a high circulation of the 20A (B.1, B.1.416 and B.1.620) and 20B (B.1.1.420) lineages in 2020, while most of the samples belonged to Delta variants (AY34 and AY.34.1, 22%) in 2021.
Conclusions
Despite its late involvement, COVID-19 diagnosis was routinely performed in LBV, but genomic characterization remained challenging. The genomic diversity of SARS-CoV-2 strains in Senegal reflected that observed worldwide during the first waves of the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratoire Bactériologie-Virologie CHNU Aristide le Dantec, Dakar, Sénégal.
- Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, F-75018 Paris, France.
- Medical Research Council, The Gambia.
- Institut de recherche en santé de surveillance épidémiologique et de formation IRESSEF, Dakar, Sénégal.
Zitieren
APA
Ba, A. A., Coppée, R., Dieng, A., Manneh, J., Fall, M., Gueye, K., Sene, P. Y., Ndiour, S., Samaté, D., Manga, P., Diop Diongue, O., Camara, A., Padane, A., Diallo, S., Gueye, S. B., Camara, M., Sesay, A. K., Toure-Kane, C., Mboup, S., …, & Diop-Ndiaye, H. (2024). Genomic epidemiology of SARS-CoV-2 in Senegal in 2020-2021. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17796
Vancouver
Ba AA, Coppée R, Dieng A, Manneh J, Fall M, Gueye K, et al. Genomic epidemiology of SARS-CoV-2 in Senegal in 2020-2021. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.17796
BibTeX
@article{Ba2024,
author = {Ba, Adjiratou Aissatou and Coppée, Romain and Dieng, Assane and Manneh, Jarra and Fall, Mengue and Gueye, Khadim and Sene, Pauline Yacine and Ndiour, Samba and Samaté, Dianké and Manga, Pascaline and Diop Diongue, Oumy and Camara, Abdoulaye and Padane, Abdou and Diallo, Sada and Gueye, Sokhna Bousso and Camara, Makhtar and Sesay, Abdul Karim and Toure-Kane, Coumba and Mboup, Souleymane and Charpentier, Charlotte and Diop-Ndiaye, Halimatou},
title = {Genomic epidemiology of SARS-CoV-2 in Senegal in 2020-2021},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.17796}
}
EUVIMED